Kim Schwendt

mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents

Susanne Rauch, Nicole Roth, Kim Schwendt et al. · npj Vaccines · 2021 · 163 citations · Full text

Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses

Fredrika Hellgren, Alberto Cagigi, Rodrigo Arcoverde Cerveira et al. · Nature Communications · 2023 · 46 citations · Full text

Vaccination, Unmodified Rabies, Vaccine Development +15

A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses

Klara Lenart, Fredrika Hellgren, Sebastian Ols et al. · Molecular Therapy — Methods & Clinical Development · 2022 · 43 citations · Full text

mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response

Puthupparampil V. Scaria, Nicole Roth, Kim Schwendt et al. · npj Vaccines · 2024 · 27 citations · Full text

mRNA based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus neutralizing antibodies and mediates protection in rodents

Susanne Rauch, Nicole Roth, Kim Schwendt et al. · 2020 · 26 citations · Full text

Vaccination, Vaccine Development, Vaccine Surveillance +15